Bruce Berkowitz has about 10% of the Fairholme Fund's assets in Pfizer. his long term thesis is that Pfizer will use its cash hoard to buy out or partner with smaller and more nimble drug or biotech companies. they have the cash to become a bit like a mini-Berkshire in the pharma space - the question is, will they?
-
Bruce Berkowitz has about 10% of the Fairholme Fund's assets in Pfizer. his long term thesis is that Pfizer will use its cash hoard to buy out or partner with smaller and more nimble drug or biotech companies. they have the cash to become a bit like a mini-Berkshire in the pharma space - the question is, will they?
Oct 20 15:29 pm
|Rating:
0
0
All Comments by weiwentg »Earnings Preview: Pfizer [View article]